SUDARSHAN PHARMA INDUSTRIES
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹9.75 Cr |
| Equity - Authorised | ₹35 Cr | ₹35 Cr | ₹35 Cr | ₹25 Cr | ₹13 Cr |
| Equity - Issued | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹9.75 Cr |
| Equity Paid Up | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹9.75 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹1.00 | ₹1.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹3.82 Cr | ₹3.82 Cr | - | - | - |
| Total Reserves | ₹127 Cr | ₹104 Cr | ₹88 Cr | ₹77 Cr | ₹20 Cr |
| Securities Premium | ₹58 Cr | ₹58 Cr | ₹58 Cr | ₹58 Cr | ₹7.97 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹69 Cr | ₹46 Cr | ₹30 Cr | ₹19 Cr | ₹12 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | ₹0.03 Cr | ₹0.00 Cr | - | - | - |
| Reserve excluding Revaluation Reserve | ₹127 Cr | ₹104 Cr | ₹88 Cr | ₹77 Cr | ₹20 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹155 Cr | ₹132 Cr | ₹112 Cr | ₹101 Cr | ₹30 Cr |
| Minority Interest | ₹1.22 Cr | ₹0.00 Cr | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹28 Cr | ₹9.90 Cr | ₹9.06 Cr | ₹12 Cr | ₹4.08 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹29 Cr | ₹8.79 Cr | ₹12 Cr | ₹14 Cr | ₹5.27 Cr |
| Term Loans - Institutions | ₹2.63 Cr | ₹3.12 Cr | - | - | - |
| Other Secured | ₹-4.06 Cr | ₹-2.02 Cr | ₹-2.70 Cr | ₹-2.49 Cr | ₹-1.19 Cr |
| Unsecured Loans | ₹0.79 Cr | ₹0.53 Cr | ₹1.44 Cr | ₹1.01 Cr | ₹0.86 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | ₹2.20 Cr | ₹1.35 Cr | ₹2.21 Cr | ₹1.13 Cr | ₹1.74 Cr |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | ₹-1.41 Cr | ₹-0.81 Cr | ₹-0.78 Cr | ₹-0.12 Cr | ₹-0.87 Cr |
| Deferred Tax Assets / Liabilities | ₹0.15 Cr | ₹0.08 Cr | ₹0.02 Cr | ₹0.18 Cr | ₹0.14 Cr |
| Deferred Tax Assets | ₹2.81 Cr | ₹2.19 Cr | ₹0.05 Cr | ₹0.03 Cr | - |
| Deferred Tax Liability | ₹2.96 Cr | ₹2.27 Cr | ₹0.07 Cr | ₹0.21 Cr | ₹0.14 Cr |
| Other Long Term Liabilities | ₹0.59 Cr | ₹3.19 Cr | - | - | - |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹0.20 Cr | ₹0.16 Cr | ₹0.42 Cr | ₹0.06 Cr | ₹0.04 Cr |
| Total Non-Current Liabilities | ₹29 Cr | ₹14 Cr | ₹11 Cr | ₹13 Cr | ₹5.12 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹188 Cr | ₹92 Cr | ₹57 Cr | ₹92 Cr | ₹74 Cr |
| Sundry Creditors | ₹188 Cr | ₹92 Cr | ₹57 Cr | ₹92 Cr | ₹74 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹13 Cr | ₹6.93 Cr | ₹10 Cr | ₹7.53 Cr | ₹4.89 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹3.89 Cr | ₹0.41 Cr | ₹2.55 Cr | ₹1.35 Cr | ₹0.43 Cr |
| Interest Accrued But Not Due | ₹0.12 Cr | ₹0.10 Cr | ₹0.11 Cr | ₹0.03 Cr | ₹0.04 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹9.21 Cr | ₹6.42 Cr | ₹7.82 Cr | ₹6.15 Cr | ₹4.42 Cr |
| Short Term Borrowings | ₹248 Cr | ₹157 Cr | ₹91 Cr | ₹18 Cr | ₹24 Cr |
| Secured ST Loans repayable on Demands | ₹192 Cr | ₹135 Cr | ₹57 Cr | ₹16 Cr | ₹22 Cr |
| Working Capital Loans- Sec | ₹192 Cr | ₹135 Cr | ₹57 Cr | ₹16 Cr | ₹22 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-137 Cr | ₹-112 Cr | ₹-23 Cr | ₹-14 Cr | ₹-21 Cr |
| Short Term Provisions | ₹7.18 Cr | ₹5.19 Cr | ₹2.74 Cr | ₹0.71 Cr | ₹0.39 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹7.16 Cr | ₹5.18 Cr | ₹2.44 Cr | ₹0.64 Cr | ₹0.33 Cr |
| Provision for post retirement benefits | - | - | - | ₹0.06 Cr | ₹0.06 Cr |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹0.02 Cr | ₹0.01 Cr | ₹0.30 Cr | ₹0.01 Cr | ₹0.00 Cr |
| Total Current Liabilities | ₹456 Cr | ₹261 Cr | ₹160 Cr | ₹118 Cr | ₹103 Cr |
| Total Liabilities | ₹642 Cr | ₹406 Cr | ₹283 Cr | ₹232 Cr | ₹138 Cr |
| ASSETS | |||||
| Gross Block | ₹98 Cr | ₹38 Cr | ₹29 Cr | ₹22 Cr | ₹8.49 Cr |
| Less: Accumulated Depreciation | ₹5.32 Cr | ₹2.39 Cr | ₹3.83 Cr | ₹2.56 Cr | ₹2.03 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹93 Cr | ₹36 Cr | ₹26 Cr | ₹20 Cr | ₹6.47 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹3.44 Cr | ₹23 Cr | ₹1.88 Cr | ₹0.01 Cr | ₹0.54 Cr |
| Non Current Investments | ₹0.00 Cr | ₹0.00 Cr | ₹12 Cr | ₹12 Cr | ₹0.00 Cr |
| Long Term Investment | ₹0.00 Cr | ₹0.00 Cr | ₹12 Cr | ₹12 Cr | ₹0.00 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹0.00 Cr | ₹0.00 Cr | ₹12 Cr | ₹12 Cr | ₹0.00 Cr |
| Long Term Loans & Advances | ₹17 Cr | ₹4.51 Cr | ₹1.83 Cr | ₹1.62 Cr | ₹0.94 Cr |
| Other Non Current Assets | ₹27 Cr | ₹4.25 Cr | ₹4.35 Cr | - | - |
| Total Non-Current Assets | ₹151 Cr | ₹79 Cr | ₹46 Cr | ₹34 Cr | ₹7.94 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | ₹1.67 Cr | ₹1.50 Cr | - | - |
| Quoted | - | ₹1.67 Cr | - | - | - |
| Unquoted | - | - | ₹1.50 Cr | - | - |
| Inventories | ₹219 Cr | ₹140 Cr | ₹86 Cr | ₹75 Cr | ₹47 Cr |
| Raw Materials | ₹8.33 Cr | ₹3.91 Cr | ₹3.17 Cr | ₹0.78 Cr | - |
| Work-in Progress | - | - | - | - | - |
| Finished Goods | ₹4.99 Cr | ₹3.23 Cr | ₹1.58 Cr | ₹1.25 Cr | ₹47 Cr |
| Packing Materials | ₹0.49 Cr | ₹0.86 Cr | ₹1.21 Cr | ₹0.30 Cr | - |
| Stores ĆĀ and Spare | - | - | - | - | - |
| Other Inventory | ₹205 Cr | ₹132 Cr | ₹80 Cr | ₹72 Cr | - |
| Sundry Debtors | ₹233 Cr | ₹153 Cr | ₹123 Cr | ₹82 Cr | ₹73 Cr |
| Debtors more than Six months | ₹21 Cr | ₹22 Cr | ₹12 Cr | ₹4.77 Cr | ₹3.52 Cr |
| Debtors Others | ₹221 Cr | ₹138 Cr | ₹110 Cr | ₹77 Cr | ₹70 Cr |
| Cash and Bank | ₹1.14 Cr | ₹0.55 Cr | ₹0.14 Cr | ₹12 Cr | ₹0.24 Cr |
| Cash in hand | ₹0.06 Cr | ₹0.06 Cr | ₹0.06 Cr | ₹0.06 Cr | ₹0.02 Cr |
| Balances at Bank | ₹1.07 Cr | ₹0.49 Cr | ₹0.08 Cr | ₹12 Cr | ₹0.22 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹4.17 Cr | ₹2.97 Cr | ₹9.50 Cr | ₹1.09 Cr | ₹0.45 Cr |
| Interest accrued on Investments | ₹0.03 Cr | ₹0.04 Cr | ₹0.11 Cr | ₹0.27 Cr | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹2.97 Cr | ₹2.03 Cr | ₹1.78 Cr | ₹0.48 Cr | ₹0.18 Cr |
| Other current_assets | ₹1.16 Cr | ₹0.90 Cr | ₹7.61 Cr | ₹0.34 Cr | ₹0.27 Cr |
| Short Term Loans and Advances | ₹33 Cr | ₹29 Cr | ₹18 Cr | ₹30 Cr | ₹8.55 Cr |
| Advances recoverable in cash or in kind | ₹4.93 Cr | ₹9.79 Cr | ₹0.02 Cr | ₹0.01 Cr | ₹0.03 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹28 Cr | ₹19 Cr | ₹18 Cr | ₹30 Cr | ₹8.51 Cr |
| Total Current Assets | ₹490 Cr | ₹327 Cr | ₹237 Cr | ₹199 Cr | ₹130 Cr |
| Net Current Assets (Including Current Investments) | ₹34 Cr | ₹67 Cr | ₹77 Cr | ₹80 Cr | ₹27 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹642 Cr | ₹406 Cr | ₹283 Cr | ₹232 Cr | ₹138 Cr |
| Contingent Liabilities | ₹59 Cr | ₹29 Cr | ₹0.40 Cr | ₹0.20 Cr | ₹0.19 Cr |
| Total Debt | ₹283 Cr | ₹171 Cr | ₹105 Cr | ₹34 Cr | ₹31 Cr |
| Book Value | - | 5.30 | 46.42 | 41.96 | 30.54 |
| Adjusted Book Value | 6.29 | 5.32 | 4.64 | 4.20 | 3.05 |
Compare Balance Sheet of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹912.1 Cr | 12% | -4.1% | 53.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 12% |
-4.1% |
53.6% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses